BeStock  
Stocks › Medical Devices › PRCT

PROCEPT BioRobotics PRCT

US equityMarket cap rank #3227Medical DevicesRobotics
$17.91 +$0.40 (+2.28%)
Pre-market · Oct 8, 9:00 am ET · After hours $17.91 0.00%
Open$17.63
Prev close$17.51
Day range$17.63 – $18.46
Volume1.15M
Market cap$1.03B
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership98.2%-0.70 pts vs. prior quarter
Institutions holding311-2 vs. prior quarter
Insider trades (recent)34 buys / 11 sellsNet buying
Short interest12.99% of floatDays to cover 5.6 · as of 15 Sep 2026
Short-sale volume share20.6%5-day average of daily volume

Short-sale volume as % of daily volume

12%17%22%27%Sep '26Sep '26Oct '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$7.71M (3 inflow days, 17 outflow days).

Net flow by order size, last 20 sessions

−$3.2MSuper−$4.5MBig−$4.0MMid−$7.8MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 29.6% of shares outstanding.

Largest holders

  • BlackRock8.50%
  • T. Rowe Price Group, Inc.8.03%
  • Vanguard Capital Management, LLC5.00%
  • Vanguard Portfolio Management, LLC4.41%
  • Chicago Capital, LLC3.62%
  • State Street Global Advisors2.82%
  • Geode Capital Management, LLC2.59%
  • FMR2.52%

By investor type

  • Mutual Fund76.95%
  • Hedge Fund11.98%
  • Public Company3.99%
  • Individual/Insider2.56%
  • Private Company1.77%
  • Government Pension Fund1.70%
  • VC/PE Fund0.79%
  • Insurance Company0.60%

Reported short interest has fallen from 13.45% to 12.99% of float over the last 6 biweekly reports (30 Jun 2026 to 15 Sep 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
Federated Hermes, Inc. Mutual Fund 2026/Q3 +1,078,984 2.2%
Soleus Capital Management, L.P. Hedge Fund 2026/Q3 +843,000 1.8%
LMR Partners LLP Hedge Fund 2026/Q3 +721,608 1.3%
Janus Henderson Group plc Mutual Fund 2026/Q3 +719,158 1.9%
T. Rowe Price Group, Inc. Mutual Fund 2026/Q3 +718,404 8.0%
BlackRock Mutual Fund 2026/Q3 +507,826 8.5%
William Blair Investment Management, LLC Mutual Fund 2026/Q3 +492,964 2.2%
Frontier Capital Management Mutual Fund 2026/Q3 +481,671 1.9%
Wellington Management Group Mutual Fund 2026/Q3 +412,399 2.2%
Susquehanna International Group, LLP Private Company 2026/Q3 +205,672 0.4%
Davern Capital Partners, LP Hedge Fund 2026/Q3 +203,720 0.8%
BNP Paribas Financial Markets SNC Private Company 2026/Q3 +201,894 0.7%
Deutsche Asset & Wealth Management Mutual Fund 2026/Q3 +193,683 0.4%
Centerbook Partners LP Hedge Fund 2026/Q3 +172,192 0.4%
Healthcare of Ontario Pension Plan Trust Fund Government Pension Fund 2026/Q3 +160,581 0.3%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
1 Oct 2026 Michael Mack Independent Director Other Acquisition +7,727 – 7,727
1 Oct 2026 Michael Mack Independent Director Other Derivative Acquisition +12,191 $17.16 12,191
8 Sep 2026 Alaleh Nouri EVP, Chief Legal Officer & Corporate Secretary Open Market Disposition -297 $20.95 38,444
8 Sep 2026 Barry Templin Senior Vice President of Medical Affairs & Market Access Open Market Disposition -373 $20.95 151,283
8 Sep 2026 Kevin Waters Chief Financial Officer Open Market Disposition -373 $20.95 79,969
12 Aug 2026 Alaleh Nouri EVP, Chief Legal Officer & Corporate Secretary Other Acquisition +22,965 – 90,103
12 Aug 2026 Alaleh Nouri EVP, Chief Legal Officer & Corporate Secretary Other Derivative Acquisition +31,773 $21.95 31,773
12 Aug 2026 Barry Templin Senior Vice President of Medical Affairs & Market Access Other Acquisition +26,246 – 151,656
12 Aug 2026 Barry Templin Senior Vice President of Medical Affairs & Market Access Other Derivative Acquisition +36,312 $21.95 36,312
12 Aug 2026 Kevin Waters Chief Financial Officer Other Acquisition +29,527 – 101,405
12 Aug 2026 Kevin Waters Chief Financial Officer Other Derivative Acquisition +40,851 $21.95 40,851
12 Aug 2026 Pooja Sharma Other Acquisition +23,622 – 111,181
12 Aug 2026 Pooja Sharma Other Derivative Acquisition +32,681 $21.95 32,681
6 Aug 2026 Larry Wood Independent Director Open Market Acquisition +23,900 $20.85 26,910
8 Jun 2026 Thomas Prescott Chairperson of the Board Other Acquisition +3,315 – 4,887
8 Jun 2026 Thomas Prescott Chairperson of the Board Other Derivative Acquisition +5,853 $28.78 5,853
8 Jun 2026 Frederic Moll Independent Chairperson Other Acquisition +3,315 – 3,315
8 Jun 2026 Frederic Moll Independent Chairperson Other Derivative Acquisition +5,853 $28.78 5,853
8 Jun 2026 Taylor Harris Independent Director Other Acquisition +3,315 – 3,315
8 Jun 2026 Taylor Harris Independent Director Other Derivative Acquisition +5,853 $28.78 5,853

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
15 Sep 2026 7,440,176 13.0% 5.6
31 Aug 2026 7,248,594 12.7% 8.6
14 Aug 2026 7,705,034 13.5% 3.5
31 Jul 2026 7,091,454 12.5% 5.1
15 Jul 2026 7,753,703 13.6% 4.9
30 Jun 2026 7,654,020 13.4% 3.9

Discussion

No comments yet — be the first to weigh in on PRCT.

Leave a comment

Scroll to Top